![Tom Holgate](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Tom Holgate
Director/Board Member at BenevolentAI Cambridge Ltd.
Profile
Tom Joseph Charles Holgate is currently a Director at BenevolentAI Cambridge Ltd.
and BenevolentAI Technology Ltd.
He previously worked as a Senior Vice President & Group Finance Director at BenevolentAI SA.
Tom Holgate active positions
Companies | Position | Start |
---|---|---|
BenevolentAI Cambridge Ltd.
![]() BenevolentAI Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services BenevolentAI Cambridge Ltd. develops novel small molecule therapeutics, in particular in the areas of CNS, pain and inflammation. It specializes in drug development, project management and translational medicine. The company was founded on November 26, 2003 and is headquartered in London, the United Kingdom. | Director/Board Member | 2018-02-20 |
BenevolentAI Technology Ltd.
![]() BenevolentAI Technology Ltd. Packaged SoftwareTechnology Services Part of BenevolentAI SA, BenevolentAI Technology Ltd. is a leading, clinical-stage AI-enabled drug discovery and British development company. Founded in 2005, the company is based in London, UK. From target identification through to clinical development, their AI-enabled Benevolent Platform™ augments scientific ingenuity, with the goal of improving the probability of clinical success. The company uses AI to empower scientists to uncover new insights from data, helping to accelerate innovation and increase the probability of discovering a successful drug. The company uses machine learning to generate new insights into the underlying causes of disease and capture these insights in their knowledge graph to support drug discovery and development. In 2022, they refined and formalized their approach to sustainability, under the direction of the newly established environmental, social and governance (ESG) governance structure and teams. | Director/Board Member | 2019-05-28 |
Former positions of Tom Holgate
Companies | Position | End |
---|---|---|
BENEVOLENTAI | Director of Finance/CFO | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
BENEVOLENTAI | Health Technology |
Private companies | 2 |
---|---|
BenevolentAI Cambridge Ltd.
![]() BenevolentAI Cambridge Ltd. Miscellaneous Commercial ServicesCommercial Services BenevolentAI Cambridge Ltd. develops novel small molecule therapeutics, in particular in the areas of CNS, pain and inflammation. It specializes in drug development, project management and translational medicine. The company was founded on November 26, 2003 and is headquartered in London, the United Kingdom. | Commercial Services |
BenevolentAI Technology Ltd.
![]() BenevolentAI Technology Ltd. Packaged SoftwareTechnology Services Part of BenevolentAI SA, BenevolentAI Technology Ltd. is a leading, clinical-stage AI-enabled drug discovery and British development company. Founded in 2005, the company is based in London, UK. From target identification through to clinical development, their AI-enabled Benevolent Platform™ augments scientific ingenuity, with the goal of improving the probability of clinical success. The company uses AI to empower scientists to uncover new insights from data, helping to accelerate innovation and increase the probability of discovering a successful drug. The company uses machine learning to generate new insights into the underlying causes of disease and capture these insights in their knowledge graph to support drug discovery and development. In 2022, they refined and formalized their approach to sustainability, under the direction of the newly established environmental, social and governance (ESG) governance structure and teams. | Technology Services |
- Stock Market
- Insiders
- Tom Holgate